Article
Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.
PloS one - 1 Jan 2016
Tota Joseph E, Jiang Mengzhu, Ramanakumar Agnihotram V, Walter Stephen D, Kaufman Jay S, Coutlée François, Richardson Harriet, Burchell Ann N, Koushik Anita, Mayrand Marie Hélène, Villa Luisa L, Franco Eduardo L
Abstract excerpt
BACKGROUND: Millions of women have been vaccinated with one of two first-generation human papillomavirus (HPV) vaccines. Both vaccines remain in use and target two oncogenic types (HPVs 16 and 18); however, if these types naturally compete with others that are not targeted, type replacement may occur following reductions in the circulating prevalence of targeted types. To explore the potential for type...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.